Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
Bernstein raised its price target for Micron Technology (MU.O) from $510 to $1,300.
2026-06-22
Bernstein raised its price target for Micron Technology (MU.O) from $510 to $1,300.
Back
Other News
2026-06-22
Domestic News: 1. Pan Gongsheng, Governor of the People's Bank of China, met with the Indonesian Minister of Finance. 2. The total number of cross-regional trips during the three-day Dragon Boat Festival holiday is expected to exceed 650 million.
Domestic News: 1. Pan Gongsheng, Governor of the People's Bank of China, met with the Indonesian Minister of Finance. 2. The total number of cross-regional trips during the three-day Dragon Boat Festival holiday is expected to exceed 650 million. 3. Xiaomi Auto is offering internal purchase discounts, with some in-stock vehicles seeing price reductions of tens of thousands of yuan. 4. Kweichow Moutai: A cash dividend of 28.02 yuan per share will be distributed for 2025, with the record date being June 25, 2026. International News: 1. De la Espley won the Colombian presidential election. 2. Trump: Starmer will resign as British Prime Minister. The British Business Secretary stated there is no reason to believe the Prime Minister will resign on Monday. 3. Libya's National Oil Corporation: Crude oil production reached 1.44 million barrels per day, the highest level since 2013. 4. Iraq's Deputy Oil Minister: Iraq plans to gradually restore crude oil production to the pre-US-Iran conflict level of 4.2-4.3 million barrels per day. 5. Middle East Situation— ① US-Iran Talks: Iran claims a draft agreement on sanctions waivers for Iranian oil has been finalized. US Vice President Vance: Negotiations have made "significant" progress, and further progress is expected. ② Trump threatens Iran to stop Hezbollah or face another attack. ③ Israeli Defense Minister: Israel will not withdraw from the safe zone in Lebanon. It is understood that Israel will withdraw from some of its positions in Lebanon before the Lebanon-Israel talks this week. ④ Israel will end nationwide public restrictions, including along the Lebanon-Israel border. ⑤ US Media: Trump is disappointed that Israel "cannot handle Hezbollah" and is considering authorizing Syria to enter southern Lebanon. Syrian President: Syria is seeking an economic corridor with Lebanon, not a military one. ⑥ Iranian Media: Sources say the Strait of Hormuz will not reopen as long as the Lebanese ceasefire agreement is not observed and Iranian oil sales waivers are not approved. ⑦ In response to the Iranian president's remarks about not relinquishing his right to enrich uranium, Trump said, "He had better watch his words." ⑧ Trump stated that if no agreement is reached, the United States will become the "guardian" of the Strait and collect 20% of the Middle East's oil revenue. ⑨ Iranian military sources: The Strait remains closed.
2026-06-22
[National Medical Products Administration Approves Peleganam Spray for Marketing] On June 22, according to the National Medical Products Administration (NMPA), the NMPA recently approved the marketing of Peleganam Spray (trade name: Puyike), a Class
[National Medical Products Administration Approves Peleganam Spray for Marketing] On June 22, according to the National Medical Products Administration (NMPA), the NMPA recently approved the marketing of Peleganam Spray (trade name: Puyike), a Class 1 innovative drug submitted by Pulai Pharmaceutical (Jiangsu) Co., Ltd. This product is a topical antibacterial drug indicated for the treatment of wound infections secondary to first-degree or superficial second-degree burns caused by Staphylococcus epidermidis, Staphylococcus hemolyticus, and Acinetobacter baumannii. The approval of this drug provides patients with a new treatment option.
Chat with us
, powered by
LiveChat